Tuesday May 1 | Freshnews
Neogen acquires Igenity from Merial
LANSING, Mich., May 1, 2012 /PRNewswire/ -- Neogen Corporation announced today that it has acquired the assets of the Igenity animal genomics business from Merial Limited.
Sanofi-Aventis to acquire Merck's Merial stake for $4 billion
French drug maker Sanofi-Aventis has signed a deal to buy Merck & Co.'s 50 per cent stake in their animal health joint venture Merial Ltd.
Merial Acquires Newport Laboratories
Merial, the Animal Health division of Sanofi ,announced today that it has acquired Newport Laboratories, a privately held company based in Worthington, Minnesota, and a leader in autogenous vaccines with a focus on swine and bovine production markets.
Sanofi-Aventis Upgraded by JPMorgan Chase & Co. to "Overweight"
Sanofi-Aventis was upgraded by JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating in a research note issued on Tuesday.
Take The IVOMECA (ivermectin) Spring Challenge
Merial will continue the IVOMEC Spring Challenge for the fifth year based on the success of the program for cattle producers.